Incyte led S&P 500 decliners Tuesday afternoon after the pharmaceutical firm said it will stop developing one drug and pause ...
Recursion unveils post-combination technology-enabled portfolio with more than 10 clinical and preclinical programs, 10 ...
Advancing investigation of [212Pb]VMT01 as a monotherapy and in combination with the anti-PD-1 antibody, nivolumab, in patients with previously ...
a preclinical-stage, novel bispecific antibody directed against both TSLP and IL4R, according to a release. Traders […] "Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor ...
Biosion receives over $40 million cash payment as upfront license fee and reimbursement for certain development costs & drug product materials, and 19.9% shares of common stock of Aclaris Therapeutics ...
The October 2023 leak -- which compromised DNA data, birthdates, locations and profile photos -- impacted nearly ... promise shown by our clinical and preclinical stage pipeline and will continue ...
Hosted on MSN18d
23andMe to cut 40% of workforce, end therapeutics programWhile 23andMe shares are down about 75% since the start of the year, the company's stock jumped more than 5% in after-hours .
Alector has significant cash reserves but faces high cash burn, with no immediate catalysts and uncertain prospects for its ...
Stockhead on MSN11d
Preclinical studies confirm potential of Neurizon’s lead drug to treat ALSSpecial Report: Clinical-stage biotech Neurizon Therapeutics has released positive results of preclinical studies confirming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback